Pulmonary Pharmacology and Therapeutics

Top Research Topics at Pulmonary Pharmacology & Therapeutics?

The journal primarily tackles Internal medicine, Anesthesia, Immunology, Asthma and Pharmacology. The journal focuses on Internal medicine but the discussions also offer insight into other areas such as Gastroenterology, Endocrinology and Cardiology. Topics in Anesthesia explored in it were investigated in conjunction with research in Placebo and Crossover study.

The journal explores topics in Placebo which can be helpful for research in disciplines like Adverse effect and Randomized controlled trial. While work presented in Pulmonary Pharmacology & Therapeutics provided substantial information on Immunology, it also covered topics in Bronchoalveolar lavage and Lung. It focused on Lung research but expanded to cover Pathology.

Research on Asthma addressed in it frequently intersections with the field of Airway. The main emphasis of the journal is the research on Pharmacology, emphasizing the topic of Pharmacokinetics. In Pulmonary Pharmacology & Therapeutics, Bronchodilator, Pulmonary disease, FEV1/FVC ratio, Intensive care medicine and Spirometry are investigated in conjunction with one another to address concerns in COPD research.

• Internal medicine (31.30%)
• Anesthesia (21.98%)
• Immunology (21.40%)

What are the most cited papers published in the journal?

• Reactive oxygen species as mediators in asthma. (247 citations)
• Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway. (235 citations)
• Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. (234 citations)

Research areas of the most cited articles at Pulmonary Pharmacology & Therapeutics:

Immunology, Internal medicine, COPD, Anesthesia and Pharmacology are the main subjects of interest in the journal articles. While the most cited papers focused on Immunology, they were also able to explore topics like Bronchoalveolar lavage and Lung. While Internal medicine is the key highlight in the most cited publications, thet also covered some subjects on Endocrinology and Phosphodiesterase.

What topics the last edition of the journal is best known for?

• Internal medicine
• Gene
• Enzyme

The previous edition focused in particular on these issues:

The journal investigates areas of study like Internal medicine, Pharmacology, Asthma, Inflammation and Cancer research. The Internal medicine works featured in it incorporate elements from Gastroenterology and Endocrinology. Pulmonary Pharmacology & Therapeutics facilitates discussions on Pharmacology that incorporate concepts from other fields like Vasodilation, Corticosteroid, Mometasone furoate, Glycopyrronium bromide and Indacaterol.

Topics in Asthma were tackled in line with various other fields like Anesthesia, Cohort study, Medical record, Omalizumab and Medical prescription. While work presented in the journal provided substantial information on Inflammation, it also covered topics in Fibrosis, Receptor and Dexamethasone. The study of Airway encompasses disciplines such as Immunology, as well as fields such as Adjuvant therapy and Respiratory system, all of which overlap with one another.

The most cited articles from the last journal are:

• Antihistamines and azithromycin as a treatment for COVID-19 on primary health care - A retrospective observational study in elderly patients. (7 citations)
• Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects. (5 citations)
• Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Pulmonary Pharmacology & Therapeutics (based on the number of publications) are:

• Mario Cazzola (64 papers) published 1 paper at the last edition the same number as at the previous edition,
• Clive P. Page (58 papers) published 1 paper at the last edition, 1 less than at the previous edition,
• Maria Gabriella Matera (46 papers) absent at the last edition,
• Paola Rogliani (28 papers) published 2 papers at the last edition the same number as at the previous edition,
• Luigino Calzetta (24 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Pulmonary Pharmacology & Therapeutics (based on the number of publications) are:

• King's College London (77 papers) published 2 papers at the last edition, 1 less than at the previous edition,
• National Institutes of Health (57 papers) published 1 paper at the last edition the same number as at the previous edition,
• University of Milan (53 papers) absent at the last edition,
• University of Rome Tor Vergata (52 papers) published 2 papers at the last edition the same number as at the previous edition,
• Seconda Università degli Studi di Napoli (43 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.84% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 18.18% were posted by at least one author from the top 10 institutions publishing in the journal. Another 3.64% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 7.27% of all publications and 70.91% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Resources for Further Study in Pharmacology

For students and healthcare professionals looking forward to broadening their knowledge and understanding of pulmonary pharmacology, it is valuable to expand their learning scope. Apart from Pulmonary Pharmacology & Therapeutics, there are diverse resources such as pharmacology textbooks, online courses, webinars, as well as specialized online degree programs that offer in-depth learning materials.

Particularly, medical students or professionals who are interested in distance learning or flexible study options might contemplate on enrolling in online nursing programs. These programs can offer several courses in pharmacology and can allow aspiring clinical and medical investigators to gain knowledge and skills at their own pace. Nursing schools, specifically, offer a variety of concentration areas, including specialized tracks in pharmacology, pediatrics, geriatrics and many more, thereby offering comprehensive learning.

For your convenience, you might consider exploring {anchor} the best online nursing schools in Iowa. This platform offers a ranking of the best online nursing programs, based on factors such as the quality of teaching, the diversity of courses offered, as well as the employability rate of their graduates. It provides prospective students with detailed information, helping them to choose the appropriate program that suits their study needs and career goals.

The ongoing advancement in the medical field underscores the need for continuous learning. The availability of these resources facilitates this need, providing academicians, health professionals, and students extensive opportunities for enhancing their education and skills in pharmacology and other medical sciences.